1. Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Pharmaceutical Intermediates Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2. Pharmaceutical Intermediates Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Pharmaceutical Intermediates Market – Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. Pharmaceutical Intermediates Market
10.1. Overview
10.2. Historical Analysis (2016-2020)
11. Pharmaceutical Intermediates Market Size & Forecast 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Product
11.3.1.1. Chemical Intermediates
11.3.1.1.1 By Value (USD Million) 2022-2032F
11.3.1.1.2 Market Share (%) 2022-2032F
11.3.1.1.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Bulk Drug Intermediates
11.3.1.2.1 By Value (USD Million) 2022-2032F
11.3.1.2.2 Market Share (%) 2022-2032F
11.3.1.2.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.3. Custom Intermediates
11.3.1.3.3 By Value (USD Million) 2022-2032F
11.3.1.3.4 Market Share (%) 2022-2032F
11.3.1.3.5 Y-o-Y Growth (%) 2022-2032F
11.3.2. By Application
11.3.2.1. Analgesics
11.3.2.1.1 By Value (USD Million) 2022-2032F
11.3.2.1.2 Market Share (%) 2022-2032F
11.3.2.1.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Anti-Inflammatory Drug
11.3.2.2.1 By Value (USD Million) 2022-2032F
11.3.2.2.2 Market Share (%) 2022-2032F
11.3.2.2.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Cardiovascular Drugs
11.3.2.3.3 By Value (USD Million) 2022-2032F
11.3.2.3.4 Market Share (%) 2022-2032F
11.3.2.3.5 Y-o-Y Growth (%) 2022-2032F
11.3.2.4. Anti-Diabetic Drugs
11.3.2.4.1 By Value (USD Million) 2022-2032F
11.3.2.4.2 Market Share (%) 2022-2032F
11.3.2.4.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.5. Antimicrobial Drugs
11.3.2.5.1 By Value (USD Million) 2022-2032F
11.3.2.5.2 Market Share (%) 2022-2032F
11.3.2.5.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.6. Anti-Cancer Drugs
11.3.2.6.1 By Value (USD Million) 2022-2032F
11.3.2.6.2 Market Share (%) 2022-2032F
11.3.2.6.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.7. Others
11.3.2.7.1 By Value (USD Million) 2022-2032F
11.3.2.7.2 Market Share (%) 2022-2032F
11.3.2.7.3 Y-o-Y Growth (%) 2022-2032F
11.3.3. By End User
11.3.3.1. Biotech and Pharma Companies
11.3.3.1.1 By Value (USD Million) 2022-2032F
11.3.3.1.2 Market Share (%) 2022-2032F
11.3.3.1.3 Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Research Laboratory
11.3.3.2.1 By Value (USD Million) 2022-2032F
11.3.3.2.2 Market Share (%) 2022-2032F
11.3.3.2.3 Y-o-Y Growth (%) 2022-2032F
11.3.3.3. CMOs/CROs
11.3.3.3.1 By Value (USD Million) 2022-2032F
11.3.3.3.2 Market Share (%) 2022-2032F
11.3.3.3.3 Y-o-Y Growth (%) 2022-2032F
12. North America Pharmaceutical Intermediates Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product
12.3.2. By Application
12.3.3. By End User
12.4. Country
12.4.1. United States
12.4.2. Canada
13. Europe Pharmaceutical Intermediates Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product
13.3.2. By Application
13.3.3. By End User
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia Pharmaceutical Intermediates Market Size & Forecast 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product
14.3.2. By Application
14.3.3. By End User
14.4. By Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Pharmaceutical Intermediates Market Size & Forecast 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product
15.3.2. By Application
15.3.3. By End User
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Pharmaceutical Intermediates Market Size & Forecast 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product
16.3.2. By Application
16.3.3. By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1. BASF SE
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1 Product Portfolio
18.1.4.2 Key Clients
18.1.4.3 Market Share
18.1.4.4 Recent News & Development (Last 3 Yrs.)
18.1.4.5 Executive Team
18.2. Sanofi
18.3. Pfizer
18.4. Evonik Industries AG
18.5. Arkema Inc
18.6. Vertellus Holdings LLC
18.7. Dishman Group
18.8. Aceto Corporation
18.9. Codexis Inc.
18.10. Midas Pharma GmbH
18.11. Interchem
18.12. Lonza Group
18.13. Chemcon Specialty Chemical Pvt. Ltd
18.14. Dextra Laboratories Limited
18.15. Chiracon GmbH
18.16. Other Prominent Players
19. Appendix
20. Consultant Recommendation
Select License Type
Our Clients
We have been working with some Fortune 500+ clients
.png){kind=icon}
